8-K - Corvus Pharmaceuticals, Inc. | StockGist

Current Report Details

Event Type

Other Event

Exhibits Only

Disclosure

Voluntary

Variant

8-K

Items Reported

8.01

Other Events. On January 21, 2026, Corvus Pharmaceuticals, Inc. (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) with Jeffe

Other Event

$22.15$20.82$163.6M$188.3M

9.01

Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 1.1 Underwriting Agreement, dated as of January 21, 2026, among Corvus Pharmaceuticals,

Exhibits Only

Exhibits (3)

1.1

EXHIBIT 1.1

5.1

EXHIBIT 5.1

8-K

FORM 8-K